Evidence map›Paper›PMID 41537934›Full record

ArticleEuropean journal of drug metabolism and pharmacokinetics2026

Minimal Physiologically-Based Pharmacokinetic Modeling to Predict Concentration-Time Profiles of Poorly Soluble Cinacalcet Hydrochloride in Fasting and Fed State.

Xiaoqian Xie, Le Sun

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of drug metabolism and pharmacokinetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaoqian XieDepartment of Pharmaceutics, School of Pharmacy, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, 110122, China.
Le SunDepartment of Pharmaceutics, School of Pharmacy, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, 110122, China. lesun@cmu.edu.cn.ORCID http://orcid.org/0000-0003-1263-5540

Funding

National Natural Science Foundation of China No. 81603055
6 · The paper itself

Abstract

BACKGROUND AND

objectiveObtaining pharmacokinetic curves is crucial for drug dosage selection, and for assessment of efficacy and adverse effects in clinical practice. The aim of this study was to utilize a minimal physiologically-based pharmacokinetic model to predict concentration-time profiles of cinacalcet hydrochloride, a poorly soluble drug, under fasting and fed conditions, and further to establish correlations between in vivo and in vitro dissolution profiles of cinacalcet hydrochloride.

methodsThe mPBPK model consisted of six tissue compartments, and an additional compartmental absorption and transit model, incorporating the stomach, seven small intestinal compartments, and the large intestine along with Johnson's equation, was integrated to enable precise calculations of in vivo dissolution.

resultsExternal validations for three dosages showed that the average fold error and the absolute average fold error were all within a two-fold error range, indicating the accuracy and reliability of the established model. Subsequently, the model was used to calculate the in vivo dissolution profile and to establish a correlation with the in vitro dissolution profile (R

conclusionThe mPBPK model can accurately predict the plasma concentration-time curves under both fasted and fed conditions, and provides a new perspective for establishing in vivo-in vitro correlations of drug products such as incomplete in vivo release, sustained/controlled release, and poor absorption.

Indexed as

CinacalcetFastingModels, BiologicalHumansMaleReproducibility of ResultsSolubilityCinacalcet

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.